Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats

Biomedicine and Pharmacotherapy

Volumn 62, Issue 9, 2008, Pages 567-572

  Zhao, Xuan ^a   Zhang, Jun Jie ^a   Wang, Xin ^a   Bu, Xiu Yun ^a   Lou, Ya Qing ^a   Zhang, Guo Liang ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Berberine; Cytochrome P450 1A2 (CYP1A2); Cytochrome P450 2E1 (CYP2E1); Diethylnitrosamine (DEN); Phenobarbital

Indexed keywords

BERBERINE; CHLORZOXAZONE; CYCLINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; DIETHYLNITROSAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; PHENACETIN; PHENOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; BERBERINE; CARCINOGENS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; DIETHYLNITROSAMINE; HEPATOCYTES; ISOENZYMES; MALE; MICROSOMES, LIVER; NITRIC OXIDE SYNTHASE TYPE II; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 54049130500     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.02.009     Document Type: Article

References (32)

1. Hwang B.Y., Roberts S.K., Chadwick L.R., Wu C.D., and Kinghorn A.D. Antimicrobial constituents from goldenseal (the Rhizomes of Hydrastis canadensis) against selected oral pathogens. Planta Media 69 (2003) 623-627
2. Kuo C.L., Chi C.W., and Liu T.Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203 (2004) 127-137
3. Iizuka N., Miyamoto K., Okita K., Tangoku A., Hayashi H., Yosino S., et al. Inhibitory effect of Coptidis rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 148 (2000) 19-25
4. Janbaz K.H., and Gilani A.H. Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia 71 (2000) 25-33
5. Hwang J.M., Wang C.J., Chou F.P., Tseng T.H., Hsieh Y.S., Lin W.L., et al. Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver. Arch Toxicol 76 (2002) 664-670
6. Lin C.C., Ng T.L., Hsu F.F., Shieh D.E., and Chiang L.C. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth. Clin Exp Pharmacol Physiol 31 (2004) 65-69
7. Anis K.V., Rajeshkumar N.V., and Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pham Pharmacol 53 (2001) 763-768
8. Hasler J.A., Estabrook R., Murray M., Pikuleva I., Waterman M., and Capdevila J. Human cytochromes P450. Mol Aspects Med 20 (1999) 1-137
9. Guengerich F.P. Forging the links between metabolism and carcinogenesis. Mutat Res 488 (2001) 195-209
10. Gallagher E.P., Kunze K.L., Stapleton P.L., and Eaton D.L. The kinetics of afatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 141 (1996) 595-606
11. Bradford B.U., Kono H., Isayama F., Kosyk O., Wheeler M.D., Akiyama T.E., et al. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41 (2005) 336-344
12. Lin H.L., and Hollenberg P.F. N-nitrosodimethylamine-mediated formation of oxidized and methylated DNA bases in a cytochrome P450 2E1 expressing cell line. Chem Res Toxicol 14 (2001) 562-566
13. Spinardi-Barbisan A.L., Kaneno R., Marchesan-Rodriguesa M.A., Favero Salvadori D.M., Trindade-Moreira E.L., Barbisan L.F., et al. Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats. Cancer Lett 154 (2000) 121-129
14. Thirunavukkarasu C., and Sakthisekaran D. Effect of dietary selenite on N-nitrosodiethylamine-induced and phenobarbital promoted multistage hepatocarcinogenesis in rat: reflection in some minerals. Biomed Pharmacother 57 (2003) 416-421
15. Hung C.R. Role of gastric oxidative stress and nitric oxide in formation of hemorrhagic erosion in rats with ischemic brain. World J Gastroenterol 28 (2006) 574-581
16. Zhu F.Q., and Qian C.Y. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 7 (2006) 78-87
17. Ahn B., Han B.S., Kim D.J., and Ohshima H. Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine. Carcinogenesis 20 (1999) 1337-1344
18. Gut I., Terelius Y., Frantik E., Linhart I., Soucek P., Filipcova B., et al. Exposure to various benzene derivates differently induces cytochromes P450 2B1 and P450 2E1 in rat liver. Arch Toxicol 67 (1993) 237-243
19. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes: I. Evidence for its hemoprotein nature. J Biol Chem 239 (1964) 2370-2378
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
21. Mizuno D., Tanaka E., Tanno K., and Misawa S. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats. Arch Toxicol 74 (2000) 139-144
22. Eagling V.A., Tjia J.F., and Back D.J. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br J Clin Pharmacol 45 (1998) 107-114
23. Tanaka E., Ishikawa A., and Misawa S. Simplified test for determination of drug-oxidizing capacity in rats with chemical-induced liver injury using caffeine and trimethadione as model drugs. Pharmacol Toxicol 70 (1992) 177-180
24. Dragan Y.P., Campbell H.A., Baker K., Vaughan J., Mass M., and Pitot H.C. Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats. Carcinogenesis 15 (1994) 2587-2591
25. Cerutti P.A. Prooxidant states and tumor promotion. Science 227 (1985) 375-381
26. Breimer L.H. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol Carcinog 3 (1990) 188-197
27. Zhang G.L., Wang Y.H., Ni W., Teng H.L., and Lin Z.B. Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J Gastroenterol 8 (2002) 728-733
28. Lee D.U., Kang Y.J., Park M.K., Lee Y.S., Seo H.G., and Kim T.S. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-a, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci 73 (2003) 1401-1412
29. Pan L.R., Tang Q., Fu Q., Hu B.R., Xiang J.Z., and Qian J.Q. Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice. Acta Pharmacol Sin 26 (2005) 1334-1338
30. Imaoka S., Osada M., Minamiyama Y., Yukimura T., Toyokuni S., and Takemura S. Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett 203 (2004) 117-125
31. Chatterjee P., and Franklin M.R. Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Dispos 31 (2003) 1391-1397
32. Minamiyama Y., Takemura S., Toyokuni S., Imaoka S., Funae Y., Hirohashi K., et al. CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. Free Radic Biol Med 37 (2004) 703-712